268 related articles for article (PubMed ID: 10655787)
1. [Effect of mixing of fine carrier particles on dry powder inhalation property of salbutamol sulfate (SS)].
Iida K; Leuenberger H; Fueg LM; Müller-Walz R; Okamoto H; Danjo K
Yakugaku Zasshi; 2000 Jan; 120(1):113-9. PubMed ID: 10655787
[TBL] [Abstract][Full Text] [Related]
2. [Effect of separation characteristics between salbutamol sulfate (SS) particles and model carrier excipients on dry powder for inhalation].
Iida K; Leuenberger H; Fueg LM; Müller-Walz R; Danjo K
Yakugaku Zasshi; 1999 Oct; 119(10):752-62. PubMed ID: 10518459
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of flow properties of dry powder inhalation of salbutamol sulfate with lactose carrier.
Iida K; Hayakawa Y; Okamoto H; Danjo K; Leuenberger H
Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1326-30. PubMed ID: 11605663
[TBL] [Abstract][Full Text] [Related]
4. Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations.
Martin GP; Marriott C; Zeng XM
Pharm Res; 2007 Feb; 24(2):361-9. PubMed ID: 17177114
[TBL] [Abstract][Full Text] [Related]
5. Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
Iida K; Inagaki Y; Todo H; Okamoto H; Danjo K; Luenberger H
Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):938-42. PubMed ID: 15304985
[TBL] [Abstract][Full Text] [Related]
6. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
Zeng XM; MacRitchie HB; Marriott C; Martin GP
Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
[TBL] [Abstract][Full Text] [Related]
7. The effects of loaded carrier mass and formulation mass on aerosolization efficiency in dry powder inhaler devices.
Ooi J; Gill C; Young PM; Traini D
Curr Drug Deliv; 2015; 12(1):40-6. PubMed ID: 25146438
[TBL] [Abstract][Full Text] [Related]
8. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
[TBL] [Abstract][Full Text] [Related]
9. Influence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier.
Iida K; Hayakawa Y; Okamoto H; Danjo K; Luenberger H
Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):444-6. PubMed ID: 15056961
[TBL] [Abstract][Full Text] [Related]
10. Effect of surface layering time of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
Iida K; Hayakawa Y; Okamoto H; Danjo K; Luenberger H
Chem Pharm Bull (Tokyo); 2004 Mar; 52(3):350-3. PubMed ID: 14993760
[TBL] [Abstract][Full Text] [Related]
11. Preparation of dry powder inhalation with lactose carrier particles surface-coated using a Wurster fluidized bed.
Iida K; Todo H; Okamoto H; Danjo K; Leuenberger H
Chem Pharm Bull (Tokyo); 2005 Apr; 53(4):431-4. PubMed ID: 15802846
[TBL] [Abstract][Full Text] [Related]
12. Micronized drug powders in binary mixtures and the effect of physical properties on aerosolization from combination drug dry powder inhalers.
Jetmalani K; Young PM; Smith T; Stewart P; Traini D
Drug Dev Ind Pharm; 2012 Dec; 38(12):1504-11. PubMed ID: 22335558
[TBL] [Abstract][Full Text] [Related]
13. The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient.
Kaialy W; Martin GP; Ticehurst MD; Momin MN; Nokhodchi A
Int J Pharm; 2010 Jun; 392(1-2):178-88. PubMed ID: 20363301
[TBL] [Abstract][Full Text] [Related]
14. Effect of surface covering of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
Iida K; Hayakawa Y; Okamoto H; Danjo K; Luenbergerb H
Chem Pharm Bull (Tokyo); 2003 Dec; 51(12):1455-7. PubMed ID: 14646332
[TBL] [Abstract][Full Text] [Related]
15. The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate.
Tee SK; Marriott C; Zeng XM; Martin GP
Int J Pharm; 2000 Nov; 208(1-2):111-23. PubMed ID: 11064216
[TBL] [Abstract][Full Text] [Related]
16. Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers.
Lucas P; Anderson K; Staniforth JN
Pharm Res; 1998 Apr; 15(4):562-9. PubMed ID: 9587952
[TBL] [Abstract][Full Text] [Related]
17. Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation.
Zeng XM; Martin GP; Tee SK; Ghoush AA; Marriott C
Int J Pharm; 1999 May; 182(2):133-44. PubMed ID: 10341303
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading.
Du P; Du J; Smyth HDC
J Pharm Sci; 2017 Jan; 106(1):366-376. PubMed ID: 27939234
[TBL] [Abstract][Full Text] [Related]
19. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols.
Zeng XM; Pandhal KH; Martin GP
Int J Pharm; 2000 Mar; 197(1-2):41-52. PubMed ID: 10704792
[TBL] [Abstract][Full Text] [Related]
20. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
